Provided by Tiger Trade Technology Pte. Ltd.

Neurocrine Biosciences

156.82
+0.24500.16%
Volume:183.38K
Turnover:28.92M
Market Cap:16.00B
PE:22.98
High:159.67
Open:157.96
Low:156.54
Close:156.57
52wk High:186.12
52wk Low:122.14
Shares:102.00M
Float Shares:100.00M
Volume Ratio:1.06
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.82
EPS(LYR):4.67
ROE:22.09%
ROA:11.70%
PB:4.33
PE(LYR):33.58

Loading ...

Dec 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Dec 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Oct 30, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 11, 2024

Major Issues Report

Form 8-K - Current report
Sep 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities